BenevolentAI is a London-based company focused on the application of artificial intelligence to challenge and reinvent the current process of drug discovery & development. The company is backed by a strong institutional and corporate shareholder base and is passionate about finding new ways to more efficiently navigate the journey of discovering drugs. As a drug discovery scientist within BenevolentAI, you will help to quickly identify and advance an exciting portfolio of drug discovery programs into clinical studies, across a range of therapeutic areas as well as developing new ways to improve and reimagine the process further.
We are looking for an innovative and creative scientist with a background in computational chemistry to make significant contributions to our technology-enabled drug discovery programmes, across all phases from target identification, lead identification & optimisation through to delivery of clinical candidates. As a central member of a dynamic, multi-disciplinary team of scientists passionate about reinventing the way new medicines are developed, you will bring your deep understanding of computational chemistry to rapidly move projects into clinical evaluation. Based at our Central London HQ in the heart of the Knowledge Quarter, you will work closely with experts in medicinal chemistry, artificial intelligence, deep learning, informatics, biological sciences and clinical translation/commercialisation to devise creative ways to reimagine the way medicines are discovered.
Must have experience:
What you’ll get:
Competitive salary, depending on experience, annual bonus, share options and comprehensive benefits.
If this challenge and opportunity excites you, please email your CV and a covering letter to our team.
No recruitment agencies please.